Why the study?
Does polycystic ovary syndrome worsen endothelial function in overweight women compared to BMI-matched controls?
Does polycystic ovary syndrome worsen endothelial function in overweight women compared to BMI-matched controls?
Overweight women with PCOS exhibit increased circulating markers of endothelial dysfunction (ADMA and PAI-1) and insulin resistance compared to BMI-matched controls, indicating higher cardiovascular risk.
Answers are grounded in this paper and cite their sources.
May indicate higher CV risk in PCOS; hypothesis-generating for endothelial markers, prospective studies needed.
PCOS (polycystic ovary syndrome) is associated with reproductive abnormalities, IR (insulin resistance) and elevated risk factors for CVD (cardiovascular disease) and Type 2 diabetes, including endothelial dysfunction. The present study aimed to assess a range of circulating markers of endothelial function in overweight women with and without PCOS. Overweight and obese age- and BMI (body mass index)-matched women with (n=80) and without (n=27) PCOS were assessed in a cross-sectional study. End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers [hsCRP (high-sensitivity C-reactive protein)] and endothelial function [FMD (flow-mediated dilation), ADMA (asymmetric dimethylarginine), PAI-1 (plasminogen activator inhibitor-1) and vWF (von Willebrand factor)]. Women with PCOS had elevated HOMA-IR (4.1+/-3.4 compared with 1.9+/-1.4), free androgen index (9.3+/-5.6 compared with 4.6+/-3.8), total cholesterol (5.2+/-1.0 compared with 4.7+/-0.9 mmol/l) and triacylglycerols (triglycerides; 1.4+/-0.7 compared with 0.9+/-0.3 mmol/l) (P<0.05 for all), but similar hsCRP compared with women without PCOS. With regard to endothelial function, women with PCOS had elevated ADMA (1.0+/-0.4 compared 0.3+/-0.1 mumol/l, P<0.001) and PAI-1 (5.6+/-1.8 compared with 4.6+/-1.1 units/ml, P=0.006), a trend towards worsened FMD (11.8+/-5.0 compared with 13.5+/-4.0%, P=0.075) and no difference in vWF compared with controls. For all subjects, ADMA (P=0.002) and PAI-1 (P<0.001) were increased with higher tertiles of HOMA-IR. Women with PCOS are hyperandrogenic, dyslipidaemic and have IR, and have risk factors for CVD and diabetes including increased circulating markers of endothelial function (ADMA and PAI-1) and a trend towards worse FMD as a global marker of endothelial function. In PCOS, deterioration in endothelial function is related to IR, hyperandrogenism and other factors.
No takes yet. Share an insight, caveat, or question.
Moran et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: